Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Nov 13, 2014 · 10-Q · 44 days after period end · 0001193125-14-411131
| Metric | Q3 2014 | Q3 2013 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$5.56M | -$3.20M |
| EPS Diluted | -$0.28 | -$4.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end
